Page 145 - 71_02
P. 145

VOL. 71 (2), 387-427, 2005  LA TOXINA BOTULÍNICA COMO MEDICAMENTO

(77)  MAUILLON, J.; THOUMAS, D.; LEROI, A. M. Y COLS. (1999): Results of pudendal
      nerve neurolysis-transposition in twelve patients suffering from pudendal
(78)  neuralgia. Dis Colon Rectum 42: 186-192.
      MCNEER, K. W.; SPENCER, R. F.; TUCKER, M. G. (1994): Observations on bi-
(79)  lateral simultaneous botulinum toxin injection in infantile esotropia. J Pe-
      diatric Ophthalmol Strabismus 31: 214-219.
(80)  MIDDLEBROOK, J. L. (1989): Cell surface receptors for protein toxins. In:
      Simpson LL, ed. Botulinum Neurotoxin and Tetanus Toxin. New York, NY:
(81)  Academic Press Inc. 95-119.
(82)  MIDDLEBROOK, J. L. (1993): Contribucións of the U.S. Army to botulinum
      toxin research. En Das Gupta B, ed. Botulinum and Tetanus Neurotoxins Y
(83)  Biomedical Aspects. New York, NY: Plenum Press 515-519.
      MIDDLEBROOK, J. L. (1996): Franz Inv y C Marzo.
(84)  MONNI, S.; RODDI, R.; BROCCARDO, M.; TURCI, R.; SAMPIETRO, L.; VILLA, E. M.
(85)  (1984): Prevention of gastroesophageal reflux. Validity of hemifunduplica-
(86)  tion according to Cor-Casolo Chir Ital 36: 151-178.
(87)  MORENO, E.; GARCÍA, A.; GARCÍA, L.; GÓMEZ, M.; RICO, P.; JOVER, J. M.; ARIAS,
(88)  J. (1988): Results of Surgical Treatment of Esophageal Acalasia. Multicen-
(89)  tric Retrospective Study of 1.856 Cases. Int Surg 73: 69-77.
      MOSCA, F.; CONSOLI, A.; LATTERI, S. (1992): Esophageal achalasia: cardiomyo-
(90)  tomy or pneumatic dilation? Minerva Chir 47: 1421-1428.
      NEILL, M. E.; SWASH, M. (1982): Chronic perianal pain: An unsolved pro-
(91)  blem. J R Soc Med 75: 96-101.
      NGUYEN, N. T.; WANG, P.; FOLLETT, D. (2000): Laparoscopy or thoracoscopy
(92)  for achalasia. Semin Thorac Cardiovasc Surg. 12 (3): 201-5.
      NICOSIA, J. F.; ABCARIAN, H. (1985): Levator syndrome. A treatment that wor-
(93)  ks. Dis Colon Rectum 28: 406-408.
      NIWAMOTO, H.; OKAMOTO, E.; FUJIMOTO, J. (1995): Are human herpes virus or
      meas-les associated with esophageal achalasia? Dig Dis Sci 40: 859-863.
      ORRINGER, M. B.; ORRINGER, J. S. (1982): Esophagectomy: Definitive Treat-
      ment for Esophageal Neuromotor Dysfunction. Ann Thorac Surg 34: 237-
      248.
      OTT, D. J.; RICHTER, J. E.; CHEN, Y. M. Y COL. (1987): Esophageal radiography
      and mano-metry: Correlation 172 patients withdysphagia. AJR 149: 307-
      311.
      PAIG, G. P.; ELLISON, R. G.; RUBIN, J. W.; MOORE, H. V. (1984): Two decades
      of experience with modified Heller’s myotomy for achalasia. Ann Thorac
      Surg 38: 201-206.
      PARICHA, P. J.; RAI, R.; RAVICH, W. J. Y COL. (1996): Botulinum toxin for
      achalasia. Long-term outcome and predictors ofresponse. Gastroenterology
      110: 1410-1415.
      PASRICHA, P. J.; RAVICH, W. J.; KALOO, A. N. (1993): Effects of intraesphinc-
      teric botulinum toxin on the lower esophageal sphincter in piglets. Gas-
      troenterology 105: 1045-1049.

                            425
   140   141   142   143   144   145   146   147   148   149   150